Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Ostendum LOAC Nanodevices are Produced with SCIENION’s sciFLEXARRAYER SX

Published: Thursday, January 30, 2014
Last Updated: Wednesday, January 29, 2014
Bookmark and Share
Best solution to precisely and accurately spot antibodies onto nanodevices.

SCIENION AG has announced that Ostendum R&D B.V., a Dutch company focused on the development and production of fast, highly sensitive, portable, easy-to-use and cost-effective biosensors, is using SCIENION’s sciFLEXARRAYER to print their unique Lab-on-a-Chip nanodevices.

Ostendum has developed a proprietary technology for the Lab-on-chip nanodevices market which has been awarded a number of awards, most recently the 2013 Frost & Sullivan Award for Technology Innovation Leadership. The technology includes both novel Lab-on-a-Chip nanodevices and an integral optical detection platform.

“We were able to experience and see the advantages of SCIENION’s sciFLEXARRAYER technology at the laboratory of Dr. Aart van Amerongen of the Biomolecular Sensing & Diagnostics group of Wageningen UR (collaborative group conducting food research as a core area)”, says Ostendum’s CEO Dr. Paul H. J. Nederkoorn. “We came to the conclusion that the sciFLEXARRAYER non-contact dispenser would be the best solution to precisely and accurately spot antibodies onto our nanodevices. After further test runs with excellent results in SCIENION’s facilities, we opted for the SX model which enables us to complete any R&D processes and to scale up for production. This compact and fully-automated system will allow high throughput production of our chips. Furthermore it is suitable for our future activities in developing higher multiplexed chips, whereas we may increase the number of channels from currently four to up to eight channels per device.”

Dr. Holger Eickhoff, CEO of SCIENION AG, states: “With its fully portable Lab-on-a-Chip system Ostendum has developed a unique technology which offers tailor-made solutions for present needs in healthcare diagnostics as well as other areas such as food and water analytics or biological warfare testing. This portable point-of-care diagnostics technology for viruses and bacteria may play an important role in future control of epidemics or biohazards. Furthermore, point-of-care diagnostics of biomarkers will enable healthcare providers with vital information to act quickly and adequately. We are very happy that Ostendum decided for the sciFLEXARRAYER SX to produce their LOC nanodevices. I am looking forward to a productive collaboration with this innovative company.”

The potential of Ostendum’s technology for changing the healthcare landscape is also reflected by recent investments of two Dutch health insurers. In May 2013, the company raised venture capital from Achmea, the largest health insurer of the Netherlands, and from de Friesland Zorgverzekeraar.

Please meet us at: Molecular Med TRI-CON, February 10-12, 2014 in San Francisco, CA, USA; booth 522. Register now for the 1st Sony DADC & SCIENION Symposium “Ideas at the point of commercialization”, March 31, 2014 in Salzburg, Austria. The agenda is available at www.scienion.com.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Tool Allows Scientists to Visualize ‘Nanoscale’ Processes
Company has announced that chemists at UC San Diego and automation experts at SCIENION have developed a new tool to Visualize ‘Nanoscale’ mixing processes occurring in liquids.
Saturday, May 07, 2016
Genalyte Teams with Scienion to Provide sciFLEXARRAYER Dispensers
Scienion’s automated liquid handling dispenser complements the simplicity, speed and flexibility of the Maverick multiplexed system.
Thursday, September 20, 2012
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Gut Model HuMiX Works Like the Real Thing
Developed by scientists at the Luxembourg Centre for Systems Biology, the “Human Microbial Cross-talk” model is representative of the actual conditions and processes that occur within our intestines.
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!